• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从原始抗原性失误到通用流感病毒疫苗。

From Original Antigenic Sin to the Universal Influenza Virus Vaccine.

机构信息

Department of Medicine, Section of Rheumatology, The Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, IL 60637, USA.

Department of Medicine, Section of Rheumatology, The Knapp Center for Lupus and Immunology Research, The University of Chicago, Chicago, IL 60637, USA.

出版信息

Trends Immunol. 2018 Jan;39(1):70-79. doi: 10.1016/j.it.2017.08.003. Epub 2017 Aug 31.

DOI:10.1016/j.it.2017.08.003
PMID:28867526
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5748348/
Abstract

Antibody responses are essential for protection against influenza virus infection. Humans are exposed to a multitude of influenza viruses throughout their lifetime and it is clear that immune history influences the magnitude and quality of the antibody response. The 'original antigenic sin' concept refers to the impact of the first influenza virus variant encounter on lifelong immunity. Although this model has been challenged since its discovery, past exposure, and likely one's first exposure, clearly affects the epitopes targeted in subsequent responses. Understanding how previous exposure to influenza virus shapes antibody responses to vaccination and infection is critical, especially with the prospect of future pandemics and for the effective development of a universal influenza vaccine.

摘要

抗体反应对于预防流感病毒感染至关重要。人类一生中会接触到多种流感病毒,很明显,免疫史会影响抗体反应的强度和质量。“原始抗原性失误”的概念是指首次遇到流感病毒变异株对终身免疫的影响。尽管自发现以来,该模型一直受到挑战,但过去的暴露,很可能是首次暴露,显然会影响随后反应中针对的表位。了解先前接触流感病毒如何影响疫苗接种和感染后的抗体反应至关重要,特别是对于未来大流行的预防以及通用流感疫苗的有效开发。

相似文献

1
From Original Antigenic Sin to the Universal Influenza Virus Vaccine.从原始抗原性失误到通用流感病毒疫苗。
Trends Immunol. 2018 Jan;39(1):70-79. doi: 10.1016/j.it.2017.08.003. Epub 2017 Aug 31.
2
Original Antigenic Sin: How First Exposure Shapes Lifelong Anti-Influenza Virus Immune Responses.原始抗原性错误:初次接触如何塑造终身抗流感病毒免疫反应。
J Immunol. 2019 Jan 15;202(2):335-340. doi: 10.4049/jimmunol.1801149.
3
Harnessing immune history to combat influenza viruses.利用免疫史对抗流感病毒。
Curr Opin Immunol. 2018 Aug;53:187-195. doi: 10.1016/j.coi.2018.05.010. Epub 2018 Jun 8.
4
Toward universal influenza virus vaccines: from natural infection to vaccination strategy.迈向通用流感病毒疫苗:从自然感染到接种策略。
Curr Opin Immunol. 2018 Aug;53:1-6. doi: 10.1016/j.coi.2018.03.020. Epub 2018 Mar 28.
5
A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.一种介导肺驻留记忆性CD8 T细胞诱导的新型疫苗接种策略赋予针对未来大流行性流感病毒的异源亚型免疫力。
J Immunol. 2016 Mar 15;196(6):2637-45. doi: 10.4049/jimmunol.1501637. Epub 2016 Feb 10.
6
Immune history and influenza virus susceptibility.免疫史与流感病毒易感性。
Curr Opin Virol. 2017 Feb;22:105-111. doi: 10.1016/j.coviro.2016.12.004. Epub 2017 Jan 12.
7
High preexisting serological antibody levels correlate with diversification of the influenza vaccine response.较高的预先存在的血清学抗体水平与流感疫苗反应的多样化相关。
J Virol. 2015 Mar;89(6):3308-17. doi: 10.1128/JVI.02871-14. Epub 2015 Jan 14.
8
Immunity to Influenza: Catching a Moving Target To Improve Vaccine Design.流感免疫:应对不断变化的目标以改进疫苗设计
J Immunol. 2019 Jan 15;202(2):327-331. doi: 10.4049/jimmunol.1890025.
9
Influenza vaccines: 'tailor-made' or 'one fits all'.流感疫苗:“量身定制”还是“一刀切”。
Curr Opin Immunol. 2018 Aug;53:102-110. doi: 10.1016/j.coi.2018.04.015. Epub 2018 May 4.
10
Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.用水泡性口炎病毒载体嵌合血凝素疫苗接种可保护小鼠免受不同流感病毒攻击毒株的侵害。
J Virol. 2015 Dec 16;90(5):2544-50. doi: 10.1128/JVI.02598-15.

引用本文的文献

1
Factors determining the outcomes of immune imprinting after repeated orthoflavivirus infections.决定反复感染黄病毒属病毒后免疫印记结果的因素。
Front Immunol. 2025 Jul 16;16:1560851. doi: 10.3389/fimmu.2025.1560851. eCollection 2025.
2
Why the Jenner/Pasteur paradigm is insufficient for controlling vector-borne diseases and the role of microbiota-mediated interactions.为什么詹纳/巴斯德范式不足以控制媒介传播疾病以及微生物群介导的相互作用的作用。
Curr Res Parasitol Vector Borne Dis. 2025 Jul 8;8:100291. doi: 10.1016/j.crpvbd.2025.100291. eCollection 2025.
3
Self-amplifying mRNA expressing COBRA hemagglutinin elicits long-lasting, broadly reactive antibodies against seasonal influenza A viruses.表达眼镜蛇血凝素的自扩增mRNA可引发针对季节性甲型流感病毒的持久、广泛反应性抗体。
Vaccine. 2025 Jul 4;62:127449. doi: 10.1016/j.vaccine.2025.127449.
4
Genetic Evolution of the Hemagglutinin Genes of Seasonal Influenza A Viruses in Türkiye Between 2017 and 2023.2017年至2023年土耳其季节性甲型流感病毒血凝素基因的遗传进化
Influenza Other Respir Viruses. 2025 Jul;19(7):e70134. doi: 10.1111/irv.70134.
5
Use of a Multiplex Immunoassay Platform to Investigate Multifaceted Antibody Responses in SARS-CoV-2 Vaccinees with and Without Prior Infection.使用多重免疫分析平台研究有或无既往感染的新冠病毒疫苗接种者的多方面抗体反应。
COVID. 2025 Apr;5(4). doi: 10.3390/covid5040044. Epub 2025 Mar 22.
6
Public antibodies: convergent signatures in human humoral immunity against pathogens.公共抗体:人类针对病原体的体液免疫中的趋同特征
mBio. 2025 May 14;16(5):e0224724. doi: 10.1128/mbio.02247-24. Epub 2025 Apr 16.
7
Structural mapping of polyclonal IgG responses to HA after influenza virus vaccination or infection.流感病毒疫苗接种或感染后针对血凝素(HA)的多克隆IgG反应的结构图谱分析
mBio. 2025 Mar 12;16(3):e0203024. doi: 10.1128/mbio.02030-24. Epub 2025 Feb 6.
8
Diversifying T-cell responses: safeguarding against pandemic influenza with mosaic nucleoprotein.多样化T细胞反应:用嵌合核蛋白防范大流行性流感
J Virol. 2025 Mar 18;99(3):e0086724. doi: 10.1128/jvi.00867-24. Epub 2025 Feb 3.
9
Impact of influenza immune imprinting on immune responses to subsequent vaccinations in mice.流感免疫印记对小鼠后续疫苗接种免疫反应的影响。
Vaccine. 2025 Feb 6;46:126670. doi: 10.1016/j.vaccine.2024.126670. Epub 2024 Dec 27.
10
Targets of influenza human T-cell response are mostly conserved in H5N1.甲型流感病毒H5N1亚型中人类T细胞应答的靶点大多是保守的。
mBio. 2025 Feb 5;16(2):e0347924. doi: 10.1128/mbio.03479-24. Epub 2024 Dec 23.

本文引用的文献

1
Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.人类自然感染H7N9病毒诱导对甲型流感病毒1组和2组血凝素的广泛交叉反应性茎特异性抗体应答
J Infect Dis. 2017 Feb 15;215(4):518-528. doi: 10.1093/infdis/jiw608.
2
Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.采用酶联免疫吸附测定法(ELISA)和酶抑制法分析儿童、成人及老年人中抗流感病毒神经氨酸酶抗体:抗原原罪的证据
mBio. 2017 Mar 21;8(2):e02281-16. doi: 10.1128/mBio.02281-16.
3
Epitope-Specific Suppression of IgG Responses by Passively Administered Specific IgG: Evidence of Epitope Masking.被动给予特异性IgG对IgG反应的表位特异性抑制:表位掩盖的证据
Front Immunol. 2017 Mar 6;8:238. doi: 10.3389/fimmu.2017.00238. eCollection 2017.
4
Universal influenza virus vaccines and therapeutic antibodies.通用流感病毒疫苗和治疗性抗体。
Clin Microbiol Infect. 2017 Apr;23(4):222-228. doi: 10.1016/j.cmi.2017.02.009. Epub 2017 Feb 12.
5
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins.定义针对流感病毒表面糖蛋白的抗体交叉反应组。
Nat Immunol. 2017 Apr;18(4):464-473. doi: 10.1038/ni.3684. Epub 2017 Feb 13.
6
Immune history and influenza virus susceptibility.免疫史与流感病毒易感性。
Curr Opin Virol. 2017 Feb;22:105-111. doi: 10.1016/j.coviro.2016.12.004. Epub 2017 Jan 12.
7
Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains.针对当前甲型H1N1流感疫苗毒株的抗体并不能保护某些个体免受当代流行的甲型H1N1流感病毒毒株的感染。
J Infect Dis. 2016 Dec 15;214(12):1947-1951. doi: 10.1093/infdis/jiw479. Epub 2016 Oct 7.
8
Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting.通过儿童期血凝素印记对H5N1和H7N9流感提供强大保护。
Science. 2016 Nov 11;354(6313):722-726. doi: 10.1126/science.aag1322.
9
Antibodies with 'Original Antigenic Sin' Properties Are Valuable Components of Secondary Immune Responses to Influenza Viruses.具有“原始抗原罪”特性的抗体是流感病毒二次免疫反应的重要组成部分。
PLoS Pathog. 2016 Aug 18;12(8):e1005806. doi: 10.1371/journal.ppat.1005806. eCollection 2016 Aug.
10
Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses.可中和1型和2型甲型流感病毒的疫苗诱导抗体。
Cell. 2016 Jul 28;166(3):609-623. doi: 10.1016/j.cell.2016.06.043. Epub 2016 Jul 21.